Home Exai Bio

Exai Bio

In operation
Series A
Developer of Liquid Biopsy Technology
Basic
Enterprise Profile

Basic Information

Exai Bio is a next-generation liquid biopsy company. Exai Bio's proprietary RNA and AI-based liquid biopsy platform provides clinical insights into cancer biology to enable the earliest and most accurate cancer diagnosis.
Exai Bio
California,United States of America
15~50 people
--
--

Enterprise Profile

Industrial Sector
Scientific Research and Experimental Development Services
Technology
Liquid Biopsy Artificial Intelligence
Concept
Tumor Laboratory Diagnosis
Application Scenarios
Early Disease Screening